A 12-week randomised, double-blinded, placebo-controlled human trial to compare the efficacy and safety of Panax ginseng berry extract and placebo on glycemic control

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CRIS

Registry ID

KCT0001589

Enrollment

Registered

2015-08-06

Start date

2014-01-23

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Main material name in the test group are panax ginseng berry extract is a soft capsule form, 2 times a day, once ingested orally 2 capsules morning/evening before meal. Main mater

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age 20-75 years with fasting glucose 100~140 mg/dL

Exclusion criteria

Exclusion criteria: Abnormal lipid profile values Acute/chronic inflammation Treated with corticosteroid within past 4 weeks Severe acute Cardiovascular disease such as Heart failure, myocardial infarction, stroke

Design outcomes

Primary

Measure	Time frame
blood glucose	—

Secondary

Measure	Time frame
blood insulin	—

Countries

Korea, Republic of

Contacts

Public ContactNam ran

Dongguk University Ilsan Hospital

Outcome results